Acerta Pharma serves as AstraZeneca's "Hematologic Oncology Center of Excellence". As such, it has the responsibility of developing both internally discovered compounds as well as AstraZeneca sourced ...
Acerta Pharma serves as AstraZeneca's "Hematologic Oncology Center of Excellence". As such, it has the responsibility of developing both internally discovered compounds as well as AstraZeneca sourced compounds for hematological malignancies. The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targeted therapies for patients with cancer.
Founded Year
2013
Organization Website
acerta-pharma.com
Organization Revenue
3000
Current Technologies
outlook
office 365
apache
google analytics
mobile friendly
Job Functions
Operations
Engineering
Consulting
Finance
Accounting
Entrepreneurship
Education
Human Resources
Business Development
hematology
oncology
pharmaceuticals
biotechnology
hospital & health care
medical
Jim Peck's Work History and Education
Acerta Pharma B.V. (A member of the AstraZeneca Group)
Clinical Trial Assistant at Acerta Pharma A Member
Present
Colleagues at
Acerta Pharma Bv A Member Of The Astrazeneca Group